BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 26376785)

  • 41. T-cell CD38 expression in B-chronic lymphocytic leukaemia.
    Abousamra NK; El-Din MS; Azmy E
    Hematol Oncol; 2009 Jun; 27(2):82-9. PubMed ID: 19247976
    [TBL] [Abstract][Full Text] [Related]  

  • 42. B cell chronic lymphocytic leukaemia/small lymphocytic lymphoma: role of ZAP70 determination on bone marrow biopsy specimens.
    Sabattini E; Orduz R; Campidelli C; Zinzani PL; Callea V; Zupo S; Cutrona G; Morabito F; Ferrarini M; Pileri S
    J Clin Pathol; 2007 Jun; 60(6):627-32. PubMed ID: 16916999
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cross-talk between DNA methylation and active histone modifications regulates aberrant expression of ZAP70 in CLL.
    Amin S; Walsh M; Wilson C; Parker AE; Oscier D; Willmore E; Mann D; Mann J
    J Cell Mol Med; 2012 Sep; 16(9):2074-84. PubMed ID: 22151263
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MDM2 SNP309 is associated with poor outcome in B-cell chronic lymphocytic leukemia.
    Gryshchenko I; Hofbauer S; Stoecher M; Daniel PT; Steurer M; Gaiger A; Eigenberger K; Greil R; Tinhofer I
    J Clin Oncol; 2008 May; 26(14):2252-7. PubMed ID: 18467716
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of ZAP-70 expression by flow cytometry in chronic lymphocytic leukemia: A multicentric international harmonization process.
    Letestu R; Rawstron A; Ghia P; Villamor N; Boeckx N; Boettcher S; Buhl AM; Duerig J; Ibbotson R; Kroeber A; Langerak A; Le Garff-Tavernier M; Mockridge I; Morilla A; Padmore R; Rassenti L; Ritgen M; Shehata M; Smolewski P; Staib P; Ticchioni M; Walker C; Ajchenbaum-Cymbalista F
    Cytometry B Clin Cytom; 2006 Jul; 70(4):309-14. PubMed ID: 16906588
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic impact of ZAP-70 expression in chronic lymphocytic leukemia: mean fluorescence intensity T/B ratio versus percentage of positive cells.
    Rossi FM; Del Principe MI; Rossi D; Irno Consalvo M; Luciano F; Zucchetto A; Bulian P; Bomben R; Dal Bo M; Fangazio M; Benedetti D; Degan M; Gaidano G; Del Poeta G; Gattei V
    J Transl Med; 2010 Mar; 8():23. PubMed ID: 20211015
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunosuppressive Treg cells acquire the phenotype of effector-T cells in chronic lymphocytic leukemia patients.
    De Matteis S; Molinari C; Abbati G; Rossi T; Napolitano R; Ghetti M; Di Rorà AGL; Musuraca G; Lucchesi A; Rigolin GM; Cuneo A; Calistri D; Fattori PP; Bonafè M; Martinelli G
    J Transl Med; 2018 Jun; 16(1):172. PubMed ID: 29925389
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of multidrug resistance-associated ABC transporters in B-CLL is independent of ZAP70 status.
    Hoellein A; Decker T; Bogner C; Oelsner M; Hauswald S; Peschel C; Keller U; Licht T
    J Cancer Res Clin Oncol; 2010 Mar; 136(3):403-10. PubMed ID: 19727816
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.
    Crespo M; Bosch F; Villamor N; Bellosillo B; Colomer D; Rozman M; Marcé S; López-Guillermo A; Campo E; Montserrat E
    N Engl J Med; 2003 May; 348(18):1764-75. PubMed ID: 12724482
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An optimized whole blood method for flow cytometric measurement of ZAP-70 protein expression in chronic lymphocytic leukemia.
    Shankey TV; Forman M; Scibelli P; Cobb J; Smith CM; Mills R; Holdaway K; Bernal-Hoyos E; Van Der Heiden M; Popma J; Keeney M
    Cytometry B Clin Cytom; 2006 Jul; 70(4):259-69. PubMed ID: 16906581
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased IL-10/IL-17 ratio is aggravated along with the prognosis of patients with chronic lymphocytic leukemia.
    Pang N; Zhang R; Li J; Zhang Z; Yuan H; Chen G; Zhao F; Wang L; Cao H; Qu J; Ding J
    Int Immunopharmacol; 2016 Nov; 40():57-64. PubMed ID: 27584054
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Spontaneous Immunity Against the Receptor Tyrosine Kinase ROR1 in Patients with Chronic Lymphocytic Leukemia.
    Hojjat-Farsangi M; Jeddi-Tehrani M; Daneshmanesh AH; Mozaffari F; Moshfegh A; Hansson L; Razavi SM; Sharifian RA; Rabbani H; Österborg A; Mellstedt H; Shokri F
    PLoS One; 2015; 10(11):e0142310. PubMed ID: 26562161
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long intergenic non-coding RNA-p21 is associated with poor prognosis in chronic lymphocytic leukemia.
    Abo Elwafa R; Abd Elrahman A; Ghallab O
    Clin Transl Oncol; 2021 Jan; 23(1):92-99. PubMed ID: 32468342
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic importance of soluble CD23 in B-cell chronic lymphocytic leukemia.
    Saka B; Aktan M; Sami U; Oner D; Sanem O; Dinçol G
    Clin Lab Haematol; 2006 Feb; 28(1):30-5. PubMed ID: 16430457
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CD49d shows superior performance characteristics for flow cytometric prognostic testing in chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Gooden CE; Jones P; Bates R; Shallenberger WM; Surti U; Swerdlow SH; Roth CG
    Cytometry B Clin Cytom; 2018 Jan; 94(1):129-135. PubMed ID: 27221715
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A novel diagnostic biosensor for distinguishing immunoglobulin mutated and unmutated types of chronic lymphocytic leukemia.
    Ensafi AA; Amini M; Rezaei B; Talebi M
    Biosens Bioelectron; 2016 Mar; 77():409-15. PubMed ID: 26436328
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of regulatory T cells in patients with B-cell chronic lymphocytic leukemia.
    Giannopoulos K; Schmitt M; Kowal M; Wlasiuk P; Bojarska-Junak A; Chen J; Rolinski J; Dmoszynska A
    Oncol Rep; 2008 Sep; 20(3):677-82. PubMed ID: 18695923
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential gene expression induction by TRAIL in B chronic lymphocytic leukemia (B-CLL) cells showing high versus low levels of Zap-70.
    Secchiero P; di Iasio MG; Gonelli A; Barbarotto E; Melloni E; Tiribelli M; Chiaruttini C; Zauli G
    J Cell Physiol; 2007 Oct; 213(1):229-36. PubMed ID: 17476690
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The proliferation center microenvironment and prognostic markers in chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Soma LA; Craig FE; Swerdlow SH
    Hum Pathol; 2006 Feb; 37(2):152-9. PubMed ID: 16426914
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Expression of Ki-67 in chronic lymphocytic leukemia and its clinical significance].
    Tan MF; Zhang ZH; Yu JJ; Qu JH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Apr; 23(2):318-21. PubMed ID: 25948178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.